Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin for persistent symptoms in subacute TBI
NCT02148367Phase 2Withdrawn
- Sponsor
- Uniformed Services University of the Health Sciences
- Start
- Sep 2014
- Primary completion
- Jun 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of erythropoietin in traumatic brain injury (TBI), sponsored by Uniformed Services University of the Health Sciences. Planned start Sep 2014; status: withdrawn.
02
Drugs
erythropoietin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT02148367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02148367.